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1234 W.-C. Wu et al.to examine the relationship between clinical biochemical parameters and the risk of prediabe-
tes among Taiwanese without the habits of consuming tobacco, alcohol drinking, or areca nut.
Methods: Women aged between 40 years and 64 years who came to one community teaching
hospital between January 1, 2001 and December 31, 2008 for general health screening for the
first time were studied. The general health screening is provided every 3 years gratis. The
package of this health screening includes personal history, physical examination, and biochem-
ical tests in serum and urine.
Results: In total, 8580 nonsmoking, nondrinking, and nonareca nut chewing women who did
not have a history of DM were eligible for this study. Of these, 1861 (21.7%) out of 8580 women
were prediabetic. Compared to women with normal fasting glucose (NFG), we found a dose-
response relationship of the risk of prediabetes with age and body mass index (BMI) and total
cholesterol, triglyceride, glutamic-pyruvic transaminase (GPT), and uric acid in serum. Women
with hypertension or proteinuria (30 mg/dL) had also an increased risk to have prediabetes.
Conclusion: Besides age, the factors of BMI, hypertension, dyslipidemia, GPT, hyperuricemia,
and proteinuria are the main risk factors for prediabetes in Taiwanese women without sub-
stance uses. A follow-up study is necessary to clarify the causality of these important biochem-
ical parameters and prediabetes.
Copyright ª 2014, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Diabetes mellitus (DM) is well known to increase the risk
of all-cause and cardiovascular disease (CVD) mortal-
ity.1e3 The associated cardiovascular risk factors are
connected with the development of micro- and macro-
vascular complications in the course of the disease,4,5 and
sometimes even prior to the diagnosis of diabetes.
Recognition is now growing that even nondiabetic levels of
hyperglycemia, as observed in impaired fasting glucose
(IFG) and impaired glucose tolerance (IGT), may also be
associated with an elevated risk of CVD and premature
mortality.4,6,7 IFG, traditionally defined as 110e125 mg/
dL, is an independent risk factor and should be aggres-
sively treated as a disease, because it produces a signifi-
cant increase in combined CVD and diabetes mortality
risks in Asian populations.8 Although the Diabetes Risk
Calculator is a readily available, noninvasive screening
tool to detect both prediabetes and undiagnosed diabetes
in the US population,9 few studies have identified the risk
factors of prediabetes in healthy Taiwanese populations
for subsequent intervention.
Substance use including cigarette smoking, alcohol drink-
ing, and areca nut chewing have been reported to be associ-
atedwithDM.Experimental studies have shownthat cigarette
smoking can impair insulin action mainly through decreasing
peripheral glucose uptake and leading to an insulin-resistant
state. Moreover, it is well known that smoking is associated
with chronic inflammation, which is a predictor of the tran-
sition from normoglycemia to IFG and increases the risk of
type 2 diabetes.10,11 Althoughmoderate alcohol drinking was
associated with a reduced risk of type 2 diabetes, heavy
alcohol drinkingwas associated with an increased risk of type
2 diabetes.12e14 For areca nut chewing, it was linked to the
newly diagnosed type 2 DM.15,16 The prevalence of cigarette
smoking, alcohol drinking, and areca nut chewing in Taiwa-
nese women is relatively low.17 By contrast, our previous
study has found that the prevalence of use of any substancewas more than half (w53%) in Taiwanese healthy men who
were from community residences and attended the hospitals
for routine physical checkups.18 To avoid the significant in-
fluence of substance use on the relationship between clinical
biochemical factors and prediabetes, we only focused on
women who did not have any habit of substance use in this
study. In addition, there are few studies examining the clin-
ical risk factors of prediabetes in Taiwanese women, thus we
pursued this inquiry by analyzing the dataset of health
screening in one community teaching hospital.Materials and methods
Study design
The study participants were women aged between 40
years and 64 years who had come to one community
teaching hospital located in Kaohsiung City of Southern
Taiwan for general health screening between January 1,
2001 and December 31, 2008 for the first time. The general
health screening is provided by the Taiwan government to
its citizens every 3 years for free. The package of this
health screening includes a history of chronic diseases and
personal lifetime habits, physical examinations such as
body height, body weight, and blood pressure monitoring,
and a morning venipuncture with fasting at least 8 hours
and collection of urine specimens for biochemistry
parameters.
Information about personal lifetime habits included
smoking cigarettes, drinking alcohol, and chewing areca
nut or not; body mass index (BMI) was calculated as weight
(kg) divided by the square of height (m2). Blood pressure
was measured using a standardized mercury column
sphygmomanometer and an appropriately sized cuff after
the individual had rested for at least 5 minutes. Two
measurements were taken and the average of the two
measurements was recorded.19
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According to the American Diabetes Association (ADA),
prediabetes is defined as a fasting serum glucose test of
100e125 mg/dL or an oral glucose tolerance test of
140e199 mg/dL. In this study, we defined the prediabetes
group as when the fasting glucose was between 100 mg/dL
and 125 mg/dL and no history of diabetes diagnosis or
antidiabetic treatment was found. Thus, women with
normal fasting glucose (NFG) were those with a serum
glucose <100 mg/dL and no history of diabetes or antidia-
betic treatment. In order to examine the risk of prediabe-
tes in women, we excluded women with NFG >125 mg/dL,
a past history of DM, or treatment of antidiabetic agents.
Statistical analysis
Mean  standard deviations or numbers with frequency
were used to describe the demographic characteristics and
clinical biochemistries when appropriate. Initially, multi-
variate logistic regression analyses were used to identify
significant determinants of prediabetes after adjusting for
age. When the significance of one covariate reached
p < 0.05, that variable was further placed in the logistic
regression models. Results derived from the logistic
regression model were shown as odds ratio and 95% confi-
dence interval (CI).
The continuous variables were categorized by quintile or
based on the normal ranges in the clinical settings. These
variables included BMI and total cholesterol, triglyceride,
glutamic-oxaloacetic transaminase (GOT), glutamic-pyruvic
transaminase (GPT), uric acid, blood urea nitrogen (BUN),
and creatinine in serum. For BMI, we classified individuals,
based on the definition from the Bureau of Health Promo-
tion of the Taiwan Government, as less-than-ideal weight
(BMI < 18.5), ideal weight (18.5  BMI < 24), overweight
(24  BMI < 27), and obese (BMI  27). For biochemical
parameters, the clinical abnormalities of serum GOT, GPT,
BUN, creatinine, and uric acid were >33 IU/L, > 34 IU/L,
>21.1 mg/dL, >1.5 mg/dL, and >8.3 mg/dL, respectively.
Hypertension was defined as systolic blood pressure
140 mmHg, diastolic blood pressure 90 mmHg, or par-
ticipants with a history of hypertension or treatment with
antihypertensive agents.
All statistical tests were two-tailed and p < 0.05 was
considered as statistically significant. All data were
analyzed by JMP (version 7.0) and SAS (version 9.1) soft-
ware (SAS Insitute Inc., Cary, NC, USA).
Results
Between January 1, 2001 and December 31, 2008, 12,183
women received health screening in this community
teaching hospital (Fig. 1). After excluding women with any
history of substance uses (tobacco, alcohol, or areca nut,
n Z 221), known DM status (n Z 948), unknown glucose
status or no information of serum glucose (n Z 186), and
lack of any information about biochemistries (total
cholesterol, triglyceride, GOT, GPT, BUN, creatinine, or
uric acid in serum or protein or white blood cells in urine) or
BMI (n Z 2248), 8580 women were eligible and wereincluded for subsequent analyses. Mean age (standard
deviation) in these 8580 eligible women was 49.9 (6.6)
years, similar to those individuals who lacked information
about biochemistries or BMI (50.4  6.7; n Z 2248).
It was found that 1861 (21.7%) of 8580 women had
fasting serum glucose testing between 100 mg/dL and
125 mg/dL. Compared to NFG women, we found higher BMI
and total cholesterol, triglyceride, GOT, GPT, BUN, and uric
acid in serum were more frequent in prediabetic women
after adjusting for age (Table S1). Women with hyperten-
sion also increased the risk of prediabetes. In addition,
women with proteinuria (30 mg/dL) had a higher risk of
having prediabetes. After considering all significant vari-
ables in the model, we found a dose-response relationship
between the risk of prediabetes and age and BMI and total
cholesterol, triglyceride, GPT, and uric acid in serum (Table
S1). By contrast, serum GOT levels were negatively and
significantly associated with the risk of prediabetes.
Women with hypertension or proteinuria (30 mg/dL)
remained at risk of prediabetes in the full model.
When categorizing BMI and biochemistries based on the
clinical references of normal ranges, we found the majority
of the results were similar to those categorized by quintiles
(Table 1). Similar results were found in the variables of age,
BMI, hypertension, and proteinuria and total cholesterol,
triglyceride, GPT, and uric acid in serum. For GOT, the
negative and significant association with the risk of pre-
diabetes was not present. By contrast, women with
abnormal serum BUN levels (>21.1 mg/dL) had a 1.25-fold
risk (95% CI Z 1.01e1.55) to have prediabetes compared
to women with normal BUN levels (Table 1).Discussion
In our study, 21.7% of women had IFG. The prevalence rate
in our study was higher than that in the community survey
from the Bureau of Health Promotion in 2002 (5.2% in
women).20 The possible explanations are: firstly, the
definition of IFG in our study was 100e125 mg/dL ac-
cording to ADA, but the definition of IFG in that study was
110e125 mg/dL by the World Health Organization; sec-
ondly, the sources of participants in our study were not
only from the community, but also patients from outpa-
tient departments who might not be healthier than those
from the community; and thirdly, although we encouraged
the study participants to fast for at least 8 hours, this
behavior could not be guaranteed. However, the potential
bias could only introduce underestimation of our findings
in this study.
There is evidence that factors are independently asso-
ciated with the development of diabetes, such as age,
family history of diabetes, waist-to-hip ratio, BMI, blood
pressure, and lipid profile levels. Current evidence shows
that the prevention of type 2 diabetes is possible through
lifestyle intervention in high-risk individuals, such as pre-
diabetics20e22 in whom beneficial changes in dietary and
exercise behaviors have been associated with reductions in
several risk factors for CVD. Some diabetes risk scores
based on simple, noninvasive, and inexpensive tools for
high-risk groups of type 2 diabetes have been re-
ported.9,23,24 An important step in preventing or delaying
Figure 1 Study flowchart. DM Z diabetes mellitus; NFG Z normal fasting glucose.
1236 W.-C. Wu et al.type 2 diabetes and its complications is to identify people
with prediabetes and undiagnosed diabetes so that they
can be given appropriate care.
Several risk factors of prediabetes in our study are
similar to those of DM, including metabolic syndrome
(overweight, hyperlipidemia, and hypertension),25 hyper-
uricemia,26 and proteinuria.27,28 In addition to those known
clinical parameters, liver function impairment, particularly
serum GPT, is one of the major risk factors for prediabetic
women. We found that serum GPT levels within the normalrange (<34 IU/L) were still a risk factor for prediabetes.
GPT is a well-known specific marker of liver pathology and
of nonalcoholic fatty liver disease. It may also be associ-
ated with obesity, fatty liver, or other hepatitis history.
Alternatively, insulin resistance has been reported to be
common in those with nonalcoholic fatty liver disease.29,30
The pathogenesis of the association between high GPT
among nondrinkers and light drinkers and the risk of type 2
DM might be in part due to nonalcoholic fatty liver disease
and insulin resistance. One study has shown that
Table 1 Relationship of demographic characteristics and clinical biochemical factors categorized by clinical normal ranges
with the risk of prediabetes in Taiwanese women.
NFG N () Prediabetes pa AOR (95% CI)b AOR (95% CI)c
n (%) n (%)
Age (y) <0.0001
40e44 2041 (30.4) 338 (18.2) 1.00
45e49 1721 (25.6) 379 (20.4) 1.15 (0.98e1.36)
50e54 1574 (23.4) 537 (28.9) 1.53 (1.31e1.80)
55e59 844 (12.6) 332 (17.8) 1.57 (1.31e1.89)
60e64 539 (8.0) 275 (14.8) 1.93 (1.58e2.35)
BMI (kg/m2) <0.0001
<18.5 189 (2.8) 19 (1.0) 0.54 (0.32e0.85) 0.61 (0.36e0.96)
18.5e23.9 3647 (54.3) 678 (36.4) 1.00 1.00
24.0e26.9 1775 (26.4) 593 (31.9) 1.67 (1.47e1.89) 1.42 (1.25e1.61)
>26.9 1108 (16.5) 571 (30.7) 2.50 (2.19e2.85) 1.87 (1.62e2.15)
Hypertension <0.0001
No 5434 (80.9) 1213 (65.2) 1.00 1.00
Yes 1285 (19.1) 648 (34.8) 1.87 (1.66e2.11) 1.52 (1.34e1.71)
Total cholesterol (mg/dL) <0.0001
<200 3002 (44.7) 633 (34.0) 1.00 1.00
200e239 2475 (36.8) 729 (39.2) 1.29 (1.15e1.46) 1.16 (1.02e1.31)
240 1242 (18.5) 499 (26.8) 1.61 (1.40e1.85) 1.31 (1.14e1.52)
Triglyceride (mg/dL) <0.0001
<150 5438 (80.9) 1268 (68.1) 1.00 1.00
150e199 718 (10.7) 297 (16.0) 1.63 (1.40e1.90) 1.26 (1.08e1.48)
200e499 545 (8.1) 273 (14.7) 1.92 (1.64e2.25) 1.33 (1.12e1.58)
500 18 (0.3) 23 (1.2) 5.01 (2.68e9.50) 3.17 (1.66e6.14)
GOT (IU/L) <0.0001
33 6323 (94.1) 1686 (90.6) 1.00 1.00
>33 396 (5.9) 175 (9.4) 1.46 (1.21e1.76) 0.89 (0.69e1.16)
GPT (IU/L) <0.0001
34 6062 (90.2) 1534 (82.4) 1.00 1.00
>34 657 (9.8) 327 (17.6) 1.82 (1.57e2.10) 1.51 (1.23e1.85)
BUN (mg/dL) <0.0001
21.1 6381 (95.0) 1700 (91.4) 1.00 1.00
>21.1 338 (5.0) 161 (8.7) 1.42 (1.16e1.73) 1.25 (1.01e1.55)
Creatinine (mg/dL) 0.041
1.5 6650 (96.8) 1825 (98.1) 1.00 1.00
>1.5 69 (1.0) 36 (1.9) 1.56 (1.03e2.35) 0.87 (0.55e1.36)
Uric acid (mg/dL) <0.0001
8.3 5376 (80.0) 1211 (65.1) 1.00 1.00
>8.3 1343 (20.0) 650 (34.9) 1.90 (1.70e2.14) 1.38 (1.22e1.56)
Proteinuria (mg/dL) <0.0001
0 or < 30 6506 (96.8) 1736 (93.3) 1.00 1.00
30 213 (3.2) 125 (6.7) 2.05 (1.63e2.58) 1.52 (1.18e1.95)
WBC in urine/HPF 0.079
0 4288 (63.8) 1,135 (61.0) 1.00
1e5 1922 (28.6) 571 (30.7) 1.11 (0.99e1.24)
>5 509 (7.6) 155 (8.3) 1.14 (0.94e1.39)
BMI Z body mass index; CI Z confidence interval; HPF Z high power field; NFG Z normal fasting glucose; WBC Z white blood cell;
GOT Z glutamic-oxaloacetic transminase; GPT Z glutamic-pyruvic transaminase; BUN Z blood urea nitrogen.
a Crude analyses.
b Adjusting for age.
c Model includes variables of age, body mass index (BMI), hypertension, total cholesterol, triglyceride, glutamic-oxaloacetic trans-
aminase (GOT), glutamic-pyruvic transaminase (GPT), blood urea nitrogen (BUN), and uric acid in serum and proteinuria.
Risk factors of prediabetes in Taiwanese women 1237nondrinkers with the highest GGT or GPT had a high risk of
type 2 diabetes.31 Our study further showed that GPT is
associated with prediabetes among nonsmoking and
nondrinking women.Several limitations were present in this study. Informa-
tion about the lifetime consumption of tobacco, alcohol,
and areca nut were collected from the questionnaire. Thus,
their accuracy is doubtful. To solve this problem, we can
1238 W.-C. Wu et al.measure several established exposure biomarkers in
different human specimens such as urinary cotinine for
cigarette smoking, serum acetaldehyde for alcohol drink-
ing, and tissue safrole-DNA adduct for areca nut, which
have proved the accuracy of questionnaires in one of our
previous studies.32 However, that strategy can only partly
solve the issue of current exposure, rather than long-time
exposure. Thus, it needs to combine a prospective cohort
design with regular follow-up to routinely collect the in-
formation about those substance uses to solve the limita-
tion of recall bias. Alternatively, to search the novel
biomarkers representative for a long-term exposure of
substance uses is necessary. In addition, information about
family history of DM is lacking in this study. Thus, we were
unable to evaluate the impact of family history of DM on the
relationship between clinical risk factors and prediabetes.
Because this study only focused on women, and lifestyle
habits, genetic expressions, and disease entity are
different between men and women, our findings cannot be
generalized to the male population. Surprisingly, we found
that women who were underweight (BMI < 18.5), compared
to those with normal weight (BMI Z 18.5e23.9), had a
significantly lower risk of having prediabetes. Our expla-
nation is that underweight women are likely to co-exist
with DM33 which those women were excluded from this
study due to cross-sectional design and cause the status of
underweight to be less likely to be prediabetes. It is
necessary to elucidate the real mechanism of this phe-
nomenon in the future. Finally, this is a cross-sectional
study; thus, the issue of causality cannot be addressed.
By contrast, the strength of this study is to focus on the
effect of the clinical biochemical parameters on the risk of
prediabetes among women who did not have any history of
substance use. Our findings will be useful for general
practitioners or family physicians to identify the high-risk
group of DM in women in the clinical setting.
In conclusion, in addition to age, BMI, hypertension, dys-
lipidemia, GPT, hyperuricemia, and proteinuria are the main
risk factors of prediabetes in Taiwanese women. A follow-up
study is necessary to clarify the causality of these important
biochemical parameters and prediabetes in women.
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